Stock-Based Compensation
$120.00M
Quarterly · Period ending: · USD
MRNA Stock-Based Compensation
Latest reported$120.00Mperiod ending
Latest reported$120.00Mperiod ending
MRNA Quarterly Stock-Based Comp ($9.33M → $120.00M)
Quarterly stock-based compensation
High-resolution chart · PNG
MRNA stock-based compensation history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 120,000,000 | |
| 104,000,000 | |
| 0 | |
| 125,000,000 | |
| 130,000,000 | |
| 115,000,000 | |
| 104,000,000 | |
| 112,000,000 | |
| 112,000,000 | |
| 101,000,000 | |
| 79,000,000 | |
| 77,000,000 | |
| 74,000,000 | |
| 75,000,000 | |
| 62,000,000 | |
| 70,000,000 | |
| 50,000,000 | |
| 44,000,000 | |
| 37,000,000 | |
| 40,000,000 | |
| 35,000,000 | |
| 30,000,000 | |
| 25,479,000 | |
| 23,206,000 | |
| 25,000,000 | |
| 20,000,000 | |
| 20,326,000 | |
| 20,804,000 | |
| 21,495,000 | |
| 18,497,000 | |
| 31,641,000 | |
| 14,720,000 | |
| 14,353,000 | |
| 11,851,000 | |
| 11,028,000 | |
| 10,365,000 | |
| 9,331,000 | |
| 9,331,000 |